Determine the Effects of C-administration of AZD7325 and an Oral Contraceptive in Healthy Female Subjects

Paused · Phase 1

Conditions studied: Pharmacokinetics

In brief

The purpose of this study is to evaluate the effect of repeated doses of AZD7325 on the pharmacokinetics of ORTHO-CYCLEN, a monophasic oral contraceptive

Key facts

Study ID

NCT00901290

Run by

AstraZeneca

People needed

56

Starts

2009-05-01

Expected to finish

2009-09-01

Last updated by the study team

2010-12-10

Who can join

Age: 18 and older, up to 45. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• If previously pregnant, must be > 6 month post-partum at the time of randomization
• Body Mass Index (BMI) greater than or equal to 18 and less than or equal to 30 kg/m2

You may not qualify if…

• Use of any prescription medication within 14 days of screening
• current smoker or history of smoking within the last 3 months prior to enrollment
• Abnormal pap smear exam result within one year of enrollment.

Where it is running

• Research Site — Overland Park, Kansas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.